長期投資家のためのIR情報
バリュートレンド

【4568】第一三共
製薬。循環器、感染症。
類似企業:
【業界1位】 武田薬品工業
【売上同水準】 アステラス製薬 中外製薬

売上高
営業利益
経常利益
当期利益
{{models[key].tabname}}
決算期 日付 予・実 売上高
(百万円)
対前回 修正率 修正率 営業利益
(百万円)
対前回 修正率 修正率 経常利益
(百万円)
対前回 修正率 修正率 当期利益
(百万円)
対前回 修正率 修正率
2025.03 2024/10/31 Q2予 1,830,000 +4.6% +4.6% 280,000 +21.7% +21.7% 285,000 +21.3% +21.3% 225,000 +18.4% +18.4%
2025.03 2024/07/31 Q1予 1,750,000 0.0% 0.0% 230,000 0.0% 0.0% 235,000 0.0% 0.0% 190,000 0.0% 0.0%
2025.03 2024/04/25 当初予 1,750,000 - - - 230,000 - - - 235,000 - - - 190,000 - - -
2024.03 2024/04/25 1,601,688 +1.4% +10.5% 211,588 +5.8% +56.7% 237,234 +15.7% +75.7% 200,731 +14.7% +74.5%
2024.03 2024/01/31 Q3予 1,580,000 +1.9% +9.0% 200,000 +33.3% +48.1% 205,000 +28.1% +51.9% 175,000 +29.6% +52.2%
2024.03 2023/10/31 Q2予 1,550,000 +6.9% +6.9% 150,000 +11.1% +11.1% 160,000 +18.5% +18.5% 135,000 +17.4% +17.4%
2024.03 2023/07/31 Q1予 1,450,000 0.0% 0.0% 135,000 0.0% 0.0% 135,000 0.0% 0.0% 115,000 0.0% 0.0%
2024.03 2023/04/27 当初予 1,450,000 - - - 135,000 - - - 135,000 - - - 115,000 - - -
2023.03 2023/04/27 1,278,478 +2.3% +11.2% 120,580 -7.2% +14.8% 126,854 -2.4% +20.8% 109,188 +9.2% +31.6%
2023.03 2023/01/31 Q3予 1,250,000 0.0% +8.7% 130,000 0.0% +23.8% 130,000 0.0% +23.8% 100,000 0.0% +20.5%
2023.03 2022/10/31 Q2予 1,250,000 +8.7% +8.7% 130,000 +23.8% +23.8% 130,000 +23.8% +23.8% 100,000 +20.5% +20.5%
2023.03 2022/07/29 Q1予 1,150,000 0.0% 0.0% 105,000 0.0% 0.0% 105,000 0.0% 0.0% 83,000 0.0% 0.0%
2023.03 2022/04/27 当初予 1,150,000 - - - 105,000 - - - 105,000 - - - 83,000 - - -
2022.03 2022/04/27 1,044,892 +1.4% +5.5% 73,025 -20.6% +4.3% 73,516 -20.1% +5.0% 66,972 +4.6% +33.9%
2022.03 2022/01/31 Q3予 1,030,000 0.0% +4.0% 92,000 0.0% +31.4% 92,000 0.0% +31.4% 64,000 0.0% +28.0%
2022.03 2021/10/29 Q2予 1,030,000 +4.0% +4.0% 92,000 +31.4% +31.4% 92,000 +31.4% +31.4% 64,000 +28.0% +28.0%
2022.03 2021/07/30 Q1予 990,000 0.0% 0.0% 70,000 0.0% 0.0% 70,000 0.0% 0.0% 50,000 0.0% 0.0%
2022.03 2021/04/27 当初予 990,000 - - - 70,000 - - - 70,000 - - - 50,000 - - -
2021.03 2021/04/27 962,516 +0.3% -0.8% 63,795 +6.3% -20.3% 74,124 +7.4% -7.3% 75,958 +43.3% +35.6%
2021.03 2021/01/29 Q3予 960,000 0.0% -1.0% 60,000 0.0% -25.0% 69,000 0.0% -13.7% 53,000 0.0% -5.4%
2021.03 2020/10/30 Q2予 960,000 -1.0% -1.0% 60,000 -25.0% -25.0% 69,000 -13.7% -13.7% 53,000 -5.4% -5.4%
2021.03 2020/07/31 Q1予 970,000 0.0% 0.0% 80,000 0.0% 0.0% 80,000 0.0% 0.0% 56,000 0.0% 0.0%
2021.03 2020/04/27 当初予 970,000 - - - 80,000 - - - 80,000 - - - 56,000 - - -
2020.03 2020/04/27 981,793 +1.2% +4.4% 138,800 +2.8% +38.8% 141,164 +4.6% +41.2% 129,074 +17.3% +79.3%
2020.03 2020/01/31 Q3予 970,000 +1.6% +3.2% 135,000 +8.0% +35.0% 135,000 +8.0% +35.0% 110,000 +22.2% +52.8%
2020.03 2019/10/31 Q2予 955,000 +1.6% +1.6% 125,000 +25.0% +25.0% 125,000 +25.0% +25.0% 90,000 +25.0% +25.0%
2020.03 2019/07/31 Q1予 940,000 0.0% 0.0% 100,000 0.0% 0.0% 100,000 0.0% 0.0% 72,000 0.0% 0.0%
2020.03 2019/04/25 当初予 940,000 - - - 100,000 - - - 100,000 - - - 72,000 - - -
2019.03 2019/04/25 929,717 +2.2% +2.2% 83,705 +7.3% +7.3% 85,831 +10.0% +10.0% 93,409 +69.8% +69.8%
2019.03 2019/01/31 Q3予 910,000 0.0% 0.0% 78,000 0.0% 0.0% 78,000 0.0% 0.0% 55,000 0.0% 0.0%
2019.03 2018/10/31 Q2予 910,000 0.0% 0.0% 78,000 0.0% 0.0% 78,000 0.0% 0.0% 55,000 0.0% 0.0%
2019.03 2018/07/31 Q1予 910,000 0.0% 0.0% 78,000 - - - 78,000 0.0% 0.0% 55,000 0.0% 0.0%
2019.03 2018/04/27 当初予 910,000 - - - - - - - 78,000 - - - 55,000 - - -
2018.03 2018/04/27 - - - - - - - - - - - - - - - -
2018.03 2018/01/31 Q3予 950,000 +2.2% +2.2% 75,000 0.0% -25.0% 75,000 0.0% -25.0% 50,000 0.0% -24.2%
2018.03 2017/10/31 Q2予 930,000 0.0% 0.0% 75,000 -25.0% -25.0% 75,000 -25.0% -25.0% 50,000 -24.2% -24.2%
2018.03 2017/07/31 Q1予 930,000 0.0% 0.0% 100,000 0.0% 0.0% 100,000 0.0% 0.0% 66,000 0.0% 0.0%
2018.03 2017/05/11 当初予 930,000 - - - 100,000 - - - 100,000 - - - 66,000 - - -
2017.03 2017/05/11 955,124 +0.5% +3.8% 88,929 -0.1% -11.1% 87,788 -0.2% -12.2% 53,466 +0.9% -17.7%
2017.03 2017/04/28 修正予 950,000 0.0% +3.3% 89,000 -19.1% -11.0% 88,000 -20.0% -12.0% 53,000 -24.3% -18.5%
2017.03 2017/01/31 Q3予 950,000 +3.3% +3.3% 110,000 +10.0% +10.0% 110,000 +10.0% +10.0% 70,000 +7.7% +7.7%
2017.03 2016/10/31 Q2予 920,000 0.0% 0.0% 100,000 0.0% 0.0% 100,000 0.0% 0.0% 65,000 0.0% 0.0%
2017.03 2016/07/29 Q1予 920,000 0.0% 0.0% 100,000 0.0% 0.0% 100,000 0.0% 0.0% 65,000 0.0% 0.0%
2017.03 2016/05/12 当初予 920,000 - - - 100,000 - - - 100,000 - - - 65,000 - - -
2016.03 2016/05/12 986,446 +0.7% +7.2% 130,412 +0.3% +30.4% 122,388 +2.0% +28.8% 82,282 +9.7% +37.1%
2016.03 2016/01/29 Q3予 980,000 0.0% +6.5% 130,000 +8.3% +30.0% 120,000 +4.3% +26.3% 75,000 0.0% +25.0%
2016.03 2015/10/30 Q2予 980,000 +3.2% +6.5% 120,000 0.0% +20.0% 115,000 0.0% +21.1% 75,000 0.0% +25.0%
2016.03 2015/07/31 Q1予 950,000 +3.3% +3.3% 120,000 +20.0% +20.0% 115,000 +21.1% +21.1% 75,000 +25.0% +25.0%
2016.03 2015/05/14 当初予 920,000 - - - 100,000 - - - 95,000 - - - 60,000 - - -
2015.03 2015/05/14 919,372 +0.0% -0.1% 74,422 +0.6% -38.0% 79,936 +1.2% -33.4% 322,119 +600.3% +313.0%
2015.03 2015/04/28 修正予 919,000 +2.1% -0.1% 74,000 -26.0% -38.3% 79,000 -21.0% -34.2% 46,000 -29.2% -41.0%
2015.03 2015/01/30 Q3予 900,000 0.0% -2.2% 100,000 0.0% -16.7% 100,000 0.0% -16.7% 65,000 0.0% -16.7%
2015.03 2014/10/31 Q2予 900,000 -2.2% -2.2% 100,000 -16.7% -16.7% 100,000 -16.7% -16.7% 65,000 -16.7% -16.7%
2015.03 2014/07/31 Q1予 920,000 0.0% 0.0% 120,000 0.0% 0.0% 120,000 0.0% 0.0% 78,000 0.0% 0.0%
2015.03 2014/05/15 当初予 920,000 - - - 120,000 - - - 120,000 - - - 78,000 - - -
2014.03 2014/05/15 1,118,241 - - - 111,552 - - - 99,775 - - - 60,943 - - -
ページトップへ戻る